Allergan Plc (AGN)

166.38
0.53 0.32
NYSE : Health Technology
Prev Close 165.85
Open 165.63
Day Low/High 165.16 / 167.21
52 Wk Low/High 114.27 / 197.00
Volume 2.85M
Avg Volume 3.80M
Exchange NYSE
Shares Outstanding 327.82M
Market Cap 54.41B
EPS -15.30
P/E Ratio N/A
Div & Yield 2.96 (1.75%)
Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Allergan Shares Fall Despite Q3 Beat, Increased Guidance

Allergan Shares Fall Despite Q3 Beat, Increased Guidance

The Dublin firm raised its outlook amid a delay in the launch of generic competition to its dry eye medication Restasis.

US Stocks Rebound as Earnings Drive Sentiment Amid Renewed Trade War Concerns

US Stocks Rebound as Earnings Drive Sentiment Amid Renewed Trade War Concerns

Global stocks attempted yet another rebound Tuesday, with reports of direction market intervention in China supporting prices in Asia and stronger-than-expected blue chip earnings putting European bourses on solid footing following a volatile session on Wall Street that saw a 900-point swing for the Dow Jones Industrial Average and a further worrying plunge in big-name tech companies.

Staying Long Apple Into Tuesday's Product Launch: Market Recon

Staying Long Apple Into Tuesday's Product Launch: Market Recon

My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.

Procter & Gamble, Western Digital, Allergan: 'Mad Money' Lightning Round

Procter & Gamble, Western Digital, Allergan: 'Mad Money' Lightning Round

Jim Cramer weighs in on Procter & Gamble, Six Flags, Western Digital, Allergan, Principal Financial Group.

Risk and Uncertainty: Cramer's 'Mad Money' Recap (Monday 7/30/18)

Risk and Uncertainty: Cramer's 'Mad Money' Recap (Monday 7/30/18)

Jim Cramer says somebody panicked, and their departure left behind a mess in the tech sector. But that spells a buying opportunity.

Aegon: Transamerica Settles Universal Life Litigation

Aegon: Transamerica Settles Universal Life Litigation

Aegon's subsidiary Transamerica today announces an agreement that would resolve litigation challenging certain monthly deduction rate adjustments on universal life insurance policies in the United States.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Aegon's US Capital Position To Benefit Significantly From Merger Of Legal Entities

Aegon's US Capital Position To Benefit Significantly From Merger Of Legal Entities

Aegon expects a one-time benefit to capital generation of approximately USD 1 billion as a result of the merger of two legal entities.

A Bullish Options Play on Allergan

A Bullish Options Play on Allergan

Buyout rumors aside, AGN is a name I still find attractive.

Aegon Announces Purchase Of Shares To Neutralize 2018 Interim Stock Dividend

Aegon Announces Purchase Of Shares To Neutralize 2018 Interim Stock Dividend

Aegon will repurchase 24,133,950 common shares to neutralize the dilutive effect of the 2018 interim stock dividend.

Allergan CEO: Botox Is in a Very Strong Position, Despite Growing Competition

Allergan CEO: Botox Is in a Very Strong Position, Despite Growing Competition

The entrance of more competition for Botox Cosmetic could expand the market, the drugmaker's top executive says at the Wells Fargo Healthcare Conference in Boston.

US Subsidiaries Aegon Reach Settlement With SEC

US Subsidiaries Aegon Reach Settlement With SEC

Today, US subsidiaries of Aegon reached a settlement with the Securities and Exchange Commission (SEC) in the matter of the operation and implementation of asset management quantitative models by Aegon's US asset management operations, and related...

Why Large-Cap Pharma Stocks Like Pfizer and Lilly Might Still Have Upside

Why Large-Cap Pharma Stocks Like Pfizer and Lilly Might Still Have Upside

A 'bullish perfect storm of technical factors' is powering the recent strength in large-cap pharma stocks, says Evercore ISI's Rich Ross.

Alibaba's Domestic Focus; Allergan Takes Another Lump -- ICYMI

Alibaba's Domestic Focus; Allergan Takes Another Lump -- ICYMI

Here's what you need to know now for Thursday, Aug. 23.

Allergan Has Finally Made a Base Pattern Traders Can Approach From the Long Side

Allergan Has Finally Made a Base Pattern Traders Can Approach From the Long Side

Let's check out the charts again so see how far this advance might carry.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:

Jim Cramer: This Is a Rotation, Not a Recession

Jim Cramer: This Is a Rotation, Not a Recession

There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.

Aegon Reports Strong First Half 2018 Results

Aegon Reports Strong First Half 2018 Results

Net income amounts to EUR 491 million supported by increase in underlying earnings Underlying earnings increase by 2% to EUR 1,064 million, or 10% on constant currencies driven by expense savings, a higher investment margin in the Netherlands, performance...

Aegon To Divest Its Businesses In Czech Republic And Slovakia

Aegon To Divest Its Businesses In Czech Republic And Slovakia

Aegon has agreed to sell its businesses in Czech Republic and Slovakia for EUR 155 million to NN Group.

Here's What Was Behind Monday's Selloff

The Dow Jones Industrial Average declined by 125 points on Monday.

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon has agreed to divest the last substantial block of its life reinsurance business to SCOR Global Life.

Let Me Report Two of the Oddest Statistics of the Day

The first is the ISE Equity Ratio which chimed in at 213%, its first reading over 200% since January 26.

Following Up on Cimarex

So where do we go from here? We have a rule to never sell into a maelstrom.

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon has agreed to divest the last substantial block of its life reinsurance business to SCOR Global Life.

Biotechs: Adding to Radius Health, Flexion

Biotechs: Adding to Radius Health, Flexion

This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.

Netflix and Twitter Are Among 29 Stocks Ready to Change Direction

Netflix and Twitter Are Among 29 Stocks Ready to Change Direction

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.

Tech Rotation Hits Market; Bullpen Update

We are looking at today's rotation as an opportunity to pick up a high-quality name at a discount.

Allergan Pushes Back on M&A Questions; Comcast Happy With Its Portfolio - ICYMI

Allergan Pushes Back on M&A Questions; Comcast Happy With Its Portfolio - ICYMI

Botox maker Allergan's CEO is pushing back against activist investors and may get help from the company's latest earnings report.

Hated Stocks May Not Always Stay Hated

Recent moves in industrial stocks demonstrate the importance of buying hated stock/groups when your conviction is high.

TheStreet Quant Rating: D+ (Sell)